Postpartum hemorrhage (PPH) is the largest contributor to maternal mortality, occurring in between 1 and 5% of deliveries. Prophylactic uterotonics are widely recommended to prevent atonic hemorrhage.

Organon, a global healthcare company focused on improving women’s health, today announced that Obstetrics & Gynecology (“The Green Journal”), the peer-reviewed journal of the American College of ...

Organon & Co. OGN announced the completion of the divestiture of its JADA System to Laborie Medical Technologies Corp. The ...

Lupin Pharmaceuticals has announced the re-introduction of Methergine (methylergonovine maleate) Oral Tablets 0.2mg for the prevention and management of postpartum hemorrhage (PPH). Lupin ...

Despite advances in obstetric care, postpartum haemorrhage (PPH), which is excessive bleeding after childbirth, continues to be the leading cause of maternal deaths worldwide. The World Health ...

According to the WHO, postpartum hemorrhage affects approximately 14 million women globally each year, resulting in about 70,000 maternal deaths. [iStockphoto] Childbirth is not only a painful process ...

Stakeholders have urged the government and other key players to promote policies and initiatives aimed at eliminating maternal deaths caused by Post-Partum Hemorrhage (PPH). Reports indicate that PPH ...

Broad global access to oxytocin, other uterotonics and oral misoprostol for PPH prevention and treatment is an important strategy to reduce PPH-related mortality. Continued institutionalization of PPH ...

Please enable JavaScript to read this content. According to the WHO, postpartum hemorrhage affects approximately 14 million women globally each year, resulting in ...